NCT00960063: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) |
|
|
| Terminated | 1 | 4 | NA | Temozolomide, Vincristine, Ifosfamide, Irinotecan, Robatumumab, Doxorubicin, Cyclophosphamide, Etoposide | Merck Sharp & Dohme LLC | Neoplasms, Solid Tumors, Bone Cancer, Kidney Tumor, Neuroblastoma | 12/10 | 12/10 | | |
